| R10766 | 
            SC-202671 | 
            JNK inhibitor IX is a selective and potent JNK inhibitor with pIC50 of 6.5 and 6
             | 
            
            
            
            
            | R10778 | 
            Pimelic diphenylamide 106; TC-H106 | 
            Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HD
             | 
            
            
            
            
            | R10779 | 
            UF010 | 
            UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μ
             | 
            
            
            
            
            | R10780 | 
            KC7F2 | 
            KC7F2 is a potent HIF-1 pathway inhibitor and that its potential as a cancer the
             | 
            
            
            
            
            | R10781 | 
            WDR50103 | 
            WDR5-0103 is a potent and selective WD repeat-containing protein 5 (WDR5) antago
             | 
            
            
            
            
            | R10793 | 
            (-)-JQ1 | 
            The bromodomain and extra terminal domain (BET) family of proteins, including BR
             | 
            
            
            
            
            | R10803 | 
            PX478 dihydrochloride | 
            PX-478 2HCl is an orally active, and selective hypoxia-inducible factor-1α (HIF-
             | 
            
            
            
            
            | R10835 | 
            Birabresib (Synonyms: OTX-015; MK-8628) | 
            OTX015 is a potent BET bromodomain inhibitor with EC50 ranging from 10 to 19 nM 
             | 
            
            
            
            
            | R10886 | 
            Domatinostat (4SC-202 free base) | 
            Domatinostat (4SC-202 free base) is a selective class I HDAC inhibitor with IC50
             | 
            
            
            
            
            | R10845 | 
            Veliparib;ABT-888 | 
            Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM a
             | 
            
            
            
            
            | R10903 | 
            CEP-33779 | 
            CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM, >40- and >800-
             | 
            
            
            
            
            | R10915 | 
            GSK3235025;EPZ-015666;GSK-3235025 | 
            EPZ015666 is a potent, selective and orally bioavailable PRMT5 inhibitor with Ki
             | 
            
            
            
            
            | R10925 | 
            ML324 | 
            ML324 is a selective inhibitor of jumonji histone demethylase (JMJD2) with IC50 
             | 
            
            
            
            
            | R10929 | 
            UNC1215 | 
            UNC1215 is a potent and selective MBT (malignant brain tumor) antagonist, which 
             | 
            
            
            
            
            | R10978 | 
            BIX-01294 | 
            BIX01294 is an inhibitor of G9a histone methyltransferase with IC50 of 2.7 μM in
             | 
            
            
            
            
            | R10981 | 
            UNC0379 | 
            UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransf
             | 
            
            
            
            
            | R10989 | 
            SGC707 | 
            SGC707 is a potent, selective and cell-active allosteric inhibitor of protein ar
             | 
            
            
            
            
            | R10990 | 
            SP2509 | 
            SP2509 is a selective histone demethylase LSD1 inhibitor with IC50 of 13 nM, sho
             | 
            
            
            
            
            | R11000 | 
            Baricitinib phosphate;LY3009104 phosphate; INCB028050 phosphate | 
            Baricitinib (LY3009104, INCB028050) is a selective JAK1 and JAK2 inhibitor with 
             | 
            
            
            
            
            | R11001 | 
            LY2784544 | 
            Gandotinib (LY2784544) is a potent JAK2 inhibitor withIC50 of 3 n
             | 
            
            
            
            
            | R11453 | 
            JNJ26854165;Quisinostat 2HCl | 
            Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with
             | 
            
            
            
            
            | R11471 | 
            GLPG0634 analog | 
            GLPG0634 analogue is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 n
             | 
            
            
            
            
            | R11501 | 
            Panobinostat (LBH589; NVP-LBH589) | 
            Panobinostat (LBH589) is a novel broad-spectrum HDAC inhibitor with IC50 of 5 nM
             | 
            
            
            
            
            | R11530 | 
            RG2833 (RGFP109) | 
            RG2833 (RGFP109) is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 n
             | 
            
            
            
            
            | R11537 | 
            Selisistat (EX-527) | 
            EX 527 (Selisistat) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM
             |